Citadel Advisors’s Pfenex Inc. PFNX Stock Holding History

Citadel Advisors’s Portfolio PFNX Stock Details PFNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-54,100	Closed	-$690K	–	11910
2020 Q3	$690K	Buy	54,100 +3,800	+8%	+$40.2K	﹤0.01%	6721
2020 Q2	$420K	Sell	50,300 -28,600	-36%	-$214K	﹤0.01%	7369
2020 Q1	$696K	Buy	78,900 +55,200	+233%	+$607K	﹤0.01%	5937
2019 Q4	$260K	Buy	+23,700	New	+$235K	﹤0.01%	7807

Other funds holding PFNX

IRAG

Investment Research & Advisory Group Atlanta, Georgia $324M AUM 22.57% 1-Year Est. Return

Citadel Advisors's PFNX Position: Q4 2020 in Review

Citadel Advisors sold out of Pfenex Inc. (PFNX) in Q4 2020, closing a stake of 23,562 shares — an estimated $300K sold.

Citadel Advisors first reported a position in PFNX in Q2 2015 and held it in 7 quarters. The position peaked at $1.05M in Q2 2015. 1 fund tracked by Wall St. Rank holds PFNX as of Q4 2020.

Citadel Advisors reported no remaining Pfenex Inc. position as of Q4 2020 after selling out during the quarter.
Citadel Advisors sold 23,562 Pfenex Inc. shares in Q4 2020, an estimated $300K.
Citadel Advisors first reported a position in Pfenex Inc. in Q2 2015 and held it in 7 quarters.
Citadel Advisors's Pfenex Inc. position peaked at $1.05M in Q2 2015.
1 fund tracked by Wall St. Rank held Pfenex Inc. as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.